Orca Bio

Head, Market Access

Menlo Park, California, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess 15+ years of U.S. market access, pricing, or payer strategy experience in biopharma, with deep expertise in oncology, hematology, or cell therapy strongly preferred. Extensive understanding of the transplant clinical landscape and cell therapy business is required, along with proven leadership in launching complex therapies in specialized settings and experience building and leading field market access teams. Strong HEOR, real-world evidence, and cost-effectiveness framework knowledge, familiarity with the U.S. reimbursement landscape including CMS and commercial payers, and excellent strategic thinking, analytical, PowerPoint, and Excel skills are essential. A Bachelor's degree is required, and an advanced degree is strongly preferred.

Responsibilities

The Head, Market Access will develop and own the U.S. market access strategy for Orca-T, aligning pricing, reimbursement, distribution, and health economics, and partner with Clinical, Medical Affairs, HEOR, and Regulatory to shape data generation supporting value propositions. Responsibilities include defining payer evidence needs, value messages, and economic models, leading launch readiness planning, directing and developing a team, fostering innovation and collaboration, overseeing access tactics like payer engagement and HUB support, partnering with trade and distribution on site-of-care strategy, and collaborating with Legal and Compliance to ensure adherence to standards and policies.

Skills

Market Access Strategy
Pricing
Reimbursement
Distribution
Health Economics
Payer Evidence
Value Propositions
Economic Models
Launch Readiness Planning
Team Leadership
Biotechnology
Cell Therapies
Blood Cancer

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI